Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment

Human Genetics

Volumn 113, Issue 6, 2003, Pages 522-533

  Gagnon, France ^a,b   Jarvik, Gail P ^b   Motulsky, Arno G ^b   Deeb, Samir S ^b   Brunzell, John D ^b   Wijsman, Ellen M ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C3; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BAYES THEOREM; CONTROLLED STUDY; DYSLIPIDEMIA; FAMILIAL HYPERLIPEMIA; GENDER; GENE LOCATION; GENETIC LINKAGE; GENETIC MODEL; GENETIC TRAIT; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MONTE CARLO METHOD; PEDIGREE; PRIORITY JOURNAL;

APOLIPOPROTEINS C; BAYES THEOREM; CHOLESTEROL, HDL; LINKAGE (GENETICS); PEDIGREE; QUANTITATIVE TRAIT LOCI;

EID: 0242690899     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-003-1006-5     Document Type: Article

References (104)

1. Albrink MJ, Krauss RM, Lindgren FT, Von Der GJ, Pan S, Wood PD (1980) Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population. Lipids 15:668-676
2. Allison DB, Heo M, Schork NJ, Wong SL, Elston RC (1998) Extreme selection strategies in gene mapping studies of oligogenic quantitative traits do not always increase power. Hum Hered 48:97-107
3. Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211
4. Almasy L, Hixson JE, Rainwater DL, Cole S, Williams JT, Mahaney MC, VandeBerg JL, Stern MP, MacCluer JW, Blangero J (1999) Human pedigree-based quantitative-trait-locus mapping: Localization of two genes influencing HDL-cholesterol metabolism. Am J Hum Genet 64:1686-1693
5. Aouizerat BE, Allayee H, Cantor RM, Dallinga-Thie GM, Lanning CD, De Bruin TW, Lusis AJ, Rotter JI (1999a) Linkage of a candidate gene locus to familial combined hyperlipidemia: Lecithin: Cholesterol acyltransferase on 16q. Arterioscler Thromb 19:2730-2736
6. Aouizerat BE, Allayee H, Cantor RM, Davis RC, Lanning CD, Wen PZ, Dallinga-Thie GM, De Bruin TW, Rotter JI, Lusis AJ (1999b) A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11. Am J Hum Genet 65:397-412
7. Arnon R, Sehayek E, Eisenberg S (1993) Disparate effects of a triglyceride lowering diet and of bezafibrate on the HDL system: A study in patients with hypertriglyceridaemia and low HDL-cholesterol levels. Eur J Clin Invest 23:492-498
8. Arya R, Duggirala R, Almasy L, Rainwater DL, Mahaney MC, Cole S, Dyer TD, Williams K, Leach RJ, Hixson JE, MacCluer JW, O'Connell P, Stern MP, Blangero J (2002) Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans. Nat Genet 30:102-105
9. Austin MA, King MC, Bawol RD, Hulley SB, Friedman GD (1987) Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences. Am J Epidemiol 125:308-318
10. Bachorik PS, Albers JJ (1986) Precipitation methods for quantitation of lipoproteins. Methods Enzymol 129:78-100
11. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22:347-351
12. Brinton EA, Eisenberg S, Breslow JL (1994) Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb 14:707-720
13. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, Van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Hayden MR. (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22:336-345
14. Brunzell JD, Schrott HG, Motulsky AG, Bierman EL (1976) Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism 25:313-320
15. Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E, McDonald GB (1983) Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res 24:147-155
16. Bucher KD, Friedlander Y, Kaplan EB, Namboodiri KK, Kark JD, Eisenberg S, Stein Y, Rifkind BM (1988) Biological and cultural sources of familial resemblance in plasma lipids: A comparison between North America and Israel - The Lipid Research Clinics Program. Genet Epidemiol 5:17-33
17. Cardon LR, Fulker DW (1994) The power of interval mapping of quantitative trait loci, using selected sib pairs. Am J Hum Genet. 55:825-833
18. Carey G, Williamson J (1991) Linkage analysis of quantitative traits: Increased power by using selected samples. Am J Hum Genet 49:786-796
19. Chapman NH, Leutenegger AL, Badzioch MD, Bogdan M, Conlon EM, Daw EW, Gagnon F, Li N, Maia JM, Wijsman EM, Thompson EA (2001) The importance of connections: Joining components of the Hutterite pedigree. Genet Epidemiol 21 Suppl 1:S230-S235
20. Cheung P, Kao FT, Law ML, Jones C, Puck TT, Chan L (1984) Localization of the structural gene for human apolipoprotein A-I on the long arm of human chromosome 11. Proc Natl Acad Sci USA 81:508-511
21. Cohen JC, Wang Z, Grundy SM, Stoesz MR, Guerra R (1994) Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest 94:2377-2384.
22. Coon G, Myers RH, Borecki IB, Arnett DK, Hunt SC, Province MA, Djousse L, Leppert MF (2000) Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study. Arterioscler Thromb 20:2275-2280
23. Coon H, Leppert MF, Eckfeldt JH, Oberman A, Myers RH, Peacock JM, Province MA, Hopkins PN, Heiss G (2001) Genome-wide linkage analysis of lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) Blood Pressure Study. Arterioscler Thromb 21:1969-1976
24. Coon H, Eckfeldt JH, Leppert MF, Myers RH, Arnett DK, Heiss G, Province MA, Hunt SC (2002) A genome-wide screen reveals evidence for a locus on chromosome 11 influencing variation in LDL cholesterol in the NHLBI Family Heart Study. Hum Genet 111:263-269
25. Daw EW, Heath SC, Wijsman EM (1999) Multipoint oligogenic analysis of age-at-onset data with applications to Alzheimer's disease pedigrees. Am J Hum Genet 64:839-851
26. Després JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B (2000) HDL-cholesterol as a marker of coronary heart disease risk: The Québec cardiovascular study. Atherosclerosis 153:263-272
27. Devlin CM, Prenger VL, Miller M (1998) Linkage of the apo CIII microsatellite with isolated low high-density lipoprotein cholesterol. Hum Genet 102:273-281
28. Duggirala R, Williams JT, Williams-Blangero S, Blangero J (1997) A variance component approach to dichotomous trait linkage analysis using a threshold model. Genet Epidemiol 14:987-992
29. Dyer TD, Blangero J, Williams JT, Goring HH, Mahaney MC (2001) The effect of pedigree complexity on quantitative trait linkage analysis. Genet Epidemiol 21 Suppl 1:S236-S243
30. Eaves L, Meyer J (1994) Locating human quantitative trait loci: Guidelines for the selection of sibling pairs of genotyping. Behav Genet 24:443-455
31. Edwards KL, Mahaney MC, Motulsky AG, Austin MA (1999) Pleiotropic genetic effects on LDL size, plasma triglyceride, and HDL cholesterol in families. Arterioscler Thromb 19:2456-2464
32. Elbein SC, Hasstedt SJ (2002) Quantitative trait linkage analysis of lipid-related traits in familial type 2 diabetes: Evidence for linkage of triglyceride levels to chromosome 19q. Diabetes 51:528-535
33. Feinleib M, Garrison RJ, Fabsitz R, Christian JC, Hrubec Z, Borhani NO, Kannel WB, Rosenman R, Schwartz JT, Wagner JO (1977) The NHLBI twin study of cardiovascular disease risk factors: Methodology and summary of results. Am J Epidemiol 106:284-285
34. Forrest WF, Feingold E (2000) Composite statistics for QTL mapping with moderately discordant sibling pairs. Am J Hum Genet 66:1642-1660
35. Friedlander Y, Kark JD, Stein Y (1986) Complex segregation analysis of low levels of plasma high-density lipoprotein cholesterol in a sample of nuclear families in Jerusalem. Genet Epidemiol 3:285-297
36. Genest JJ Jr, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH, Silberman SR, Wilson PW, Salem DN, Schaefer EJ (1992) Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85:2025-2033
37. Glueck CJ, Laskarzewski PM, Suchindran CM, Chambless LE, Barrett-Connor E, Stewart P, Heiss G, Tyroler HA (1986) Progeny's lipid and lipoprotein levels by parental mortality. The Lipid Research Clinics Program Prevalence Study. Circulation 73:151-161
38. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG (1973) Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52:1544-1568
39. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr., Bangdiwala S, Tyroler HA (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79:8-15
40. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62:707-714
41. Grundy SM, Chait A, Brunzell JD (1987) Familial combined hyperlipidemia workshop. Arterioscler Thromb 7:203-207
42. Hamsten A, Iselius L, Dahlen G, De Faire U (1986) Genetic and cultural inheritance of serum lipids, low and high density lipoprotein cholesterol and serum apolipoproteins A-I, A-II and B. Atherosclerosis 60:199-208
43. Haseman JK, Elston RC (1972) The investigation of linkage between a quantitative trait and a marker locus. Behav Genet 2:3-19
44. Hayden MR, Kirk H, Clark C, Frohlich J, Rabkin S, McLeod R, Hewitt J (1987) DNA polymorphisms in and around the Apo-A1-CIII genes and genetic hyperlipidemias. Am J Hum Genet 40:421-30
45. Heath SC (1997) Markov Chain Monte Carlo Segregation and linkage analysis for oligogenic models. Am J Hum Genet 61:748-760
46. Heath SC, Snow GL, Thompson EA, Tseng C, Wijsman EM (1997) MCMC Segregation and linkage analysis. Genet Epidemiol 14:1011-1016
47. Hegele RA, Brunt JH, Connelly PW (1995) Multiple genetic determinants of variation of plasma lipoproteins in Alberta Hutterites. Arterioscler Thromb 15:861-871
48. Heiba IM, DeMeester CA, Xia YR, Diep A, George VT, Amos CI, Srinivasan SR, Berenson GS, Elston RC, Lusis AJ (1993) Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: Analysis of a large pedigree from the Bogalusa Heart Study. Am J Med Genet 47:875-883
49. Heller DA, Pedersen NL, De Faire U, McClearn GE (1994) Genetic and environmental correlations among serum lipids and apolipoproteins in elderly twins reared together and apart. Am J Hum Genet 55:1255-67
50. Hinrichs A, Reich T (2001) Markov chain Monte Carlo linkage analysis of complex quantitative phenotypes. Genet Epidemiol 21 Suppl 1:S662-S667
51. Hong SH, Park WH, Lee CC, Song JH, Kim JQ (1997) Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects. Clin Chem 43:13-17
52. Hunt SC, Hasstedt SJ, Kuida H, Stults BM, Hopkins PN, Williams RR (1989) Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol 129:625-638
53. Imperatore G, Knowler WC, Pettitt DJ, Kobes S, Fuller JH, Bennett PH, Hanson RL (2000) A locus influencing total serum cholesterol on chromosome 19p: Results from an autosomal genomic scan of serum lipid concentrations in Pima Indians. Arterioscler Thromb 20:2651-2656
54. Jarvik GP, Wijsman EM, Little RE, Albers JJ, Motulsky AG, Brunzell JD (1993) Host and environmental effects on plasma apolipoprotein B. Int J Clin Lab Res 23:215-220
55. Jarvik GP, Brunzell JD, Austin MA, Krauss RM, Motulsky AG, Wijsman EM (1994) Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype. Arterioscler Thromb 14:1687-1694
56. Kamboh MI, Aston CE, Nestlerode CM, McAllister AE, Hamman RF (1996) Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol. Atherosclerosis 127:255-262
57. Knoblauch H, Busjahn A, Munter S, Nagy Z, Faulhaber HD, Schuster H, Luft FC (1997) Heritability analysis of lipids and three gene loci in twins link the macrophage scavenger receptor to HDL cholesterol concentrations. Arterioscler Thromb 17:2054-2060
58. Knoblauch H, Muller-Myhsok B, Busjahn A, Ben Avi L, Bahring S, Baron H, Heath SC, Uhlmann R, Faulhaber HD, Shpitzen S, Aydin A, Reshef A, Rosenthal M, Eliav O, Muhl A, Lowe A, Schurr D, Harats D, Jeschke E, Friedlander Y, Schuster H, Luft FC, Leitersdorf E (2000) A cholesterol-lowering gene maps to chromosome 13q. Am J Hum Genet 66:157-166
59. Knuiman MW, Divitini ML, Welborn TA, Bartholomew HC (1996) Familial correlations, cohabitation effects, and heritability for cardiovascular risk factors. Ann Epidemiol 6:188-194
60. Kuusi T, Kesaniemi Y, Vuoristo M, Miettinen T, Koskenvuo M (1987) Inheritance of high-density-lipoprotein and lipoprotein-lipase and hepatic lipase activity. Arterioscler Thromb 7:421-425
61. Lamarche B, Després JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ (1996) Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study. Atherosclerosis 119:235-245
62. Law SW, Gray G, Brewer HB Jr, Sakaguchi AY, Naylor SL (1984) Human apolipoprotein A-I and C-III genes reside in the p11-q13 region of chromosome 11. Biochem Biophys Res Commun 118:934-942
63. Lilja HE, Soro A, Ylitalo K, Nuotio I, Viikari JS, Salomaa V, Vartiainen E, Taskinen MR, Peltonen L, Pajukanta P (2002) A candidate gene study in low HDL-cholesterol families provides evidence for the involvement of the APOA2 gene and the APOA1C3A4 gene cluster. Atherosclerosis 164:103-111
64. MacCluer JW, Blangero J, Dyer TD, Speer MC (1997) GAW10: Simulated family data for a common oligogenic disease with quantitative risk factors. Genet Epidemiol 14:737-742
65. Mahaney MC, Blangero J, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW (1995) Plasma HDL cholesterol, triglycerides, and adiposity. A quantitative genetic test of the conjoint trait hypothesis in the San Antonio Family Heart Study. Circulation 92:3240-3248
66. Mahaney MC, Almasy L, Rainwater DL, VandeBerg JL, Cole SA, Hixson JE, Blangero J, MacCluer JW (2003) A quantitative trait locus on chromosome 16q influences variation in plasma HDL-C levels in Mexican Americans. Arterioscler Thromb 23:339-345
67. Marcil M, Brooks-Wilson A, Clee SM, Roomp K, Zhang LH, Yu L, Collins JA, Van Dam M, Molhuizen HO, Loubster O, Ouellette BF, Sensen CW, Fichter K, Mott S, Denis MR, Boucher B, Pimstone S, Genest J, Jr., Kastelein JJ, Hayden MR (1999) Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet 354:1341-1346
68. Miller NE (1990) Pharmacotherapy of disorders of plasma lipoprotein metabolism. Am J Cardiol 66:16A-19A
69. Mitchell BD, Kammerer CM, Blangero J, Mahaney MC, Rainwater DL, Dyke B, Hixson JE, Henkel RD, Sharp RM, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW (1996) Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation 94:2159-2170
70. Namboordiri KK, Kaplan EB, Heuch I, Elston RC, Green PP, Rao DC, Laskarzewski P, Glueck CJ, Rifkind BM (1985) The Collaborative Lipid Research Clinics Family Study: Biological and cultural determinants of familial resemblance for plasma lipids and lipoproteins. Genet Epidemiol 2:227-254
71. O'Connell DL, Heller RF, Roberts DC, Allen JR, Knapp JC, Steele PL, Silove D (1988) Twin study of genetic and environmental effects on lipid levels. Genet Epidemiol 5:323-341
72. Ordovas JM, Corella D, Cupples LA, Demissie S, Kelleher A, Coltell O, Wilson PW, Schaefer EJ, Tucker K (2002) Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: The Framingham Study. Am J Clin Nutr 75: 38-46
73. Pajukanta P, Terwilliger JD, Perola M, Hiekkalinna T, Nuotio I, Ellonen P, Parkkonen M, Hartiala J, Ylitalo K, Pihlajamaki J, Porkka K, Laakso M, Viikari J, Ehnholm C, Taskinen MR, Peltonen L (1999) Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet 64:1453-1463
74. Pallaud C, Gueguen R, Sass C, Grow M, Cheng S, Siest G, Visvikis S (2001) Genetic influences on lipid metabolism trait variability within the Stanislas Cohort. J Lipid Res 42:1879-1890
75. Peacock JM, Arnett DK, Atwood LD, Myers RH, Coon H, Rich SS, Province MA, Heiss G (2001) Genome scan for quantitative trait loci linked to high-density lipoprotein cholesterol: The NHLBI Family Heart Study. Arterioscler Thromb 21:1823-1828
76. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294:169-173
77. Rao DC, Laskarzewski PM, Morrison JA, Khoury P, Kelly K, Wette R, Russell J, Glueck CJ (1982) The Cincinnati Lipid Research Clinic family study: Cultural and biological determinants of lipids and lipoprotein concentrations. Am J Hum Genet 34:888-903
78. Risch N, Zhang H (1995) Extreme discordant sib pairs for mapping quantitative trait loci in humans. Science 268:1584-1589
79. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefle P, Assmann G (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22:352-255
80. Schamaun O, Olaisen B, Mevag B, Gedde-Dahl T, Jr., Ehnholm C, Teisberg P (1984) The two apolipoprotein loci apo A-I and apo A-IV are closely linked in man. Hum Genet 68:181-184
81. Shmulewitz D, Heath SC (2001) Genome scans for Q1 and Q2 on general population replicates using Loki. Genet Epidemiol 21: S686-S691
82. Seiberts SK, Wijsman EM, Thompson EA (2002) Relationship inference from trios of individuals, in the presence of typing error. Am J Hum Genet 70:170-180
83. Silverman D, Ginsburg G, Pasternak R (1993) High-density-lipoprotein subfractions. Am J Med 94:636-645
84. Snowden CB, McNamara PM, Garrison RJ, Feinleib M, Kannel WB, Epstein FH (1982) Predicting coronary heart disease in siblings - A multivariate assessment: The Framingham Heart Study. Am J Epidemiol 115:217-222
85. Song J, Park JW, Park H, Kim JQ (1998) Linkage disequilibrium of the Apo AI-CIII-AIV gene cluster and their relationship to plasma triglyceride, apolipoprotein AI and CIII levels in Koreans. Mol Cells 8:12-18
86. Soro A, Pajukanta P, Lilja HE, Ylitalo K, Hiekkalinna T, Perola M, Cantor RM, Viikari JS, Taskinen MR, Peltonen L (2002) Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish families. Am J Hum Genet 70:1333-1340
87. Sprecher DL, Hein MJ, Laskarzewski PM (1994) Conjoint high triglycerides and low HDL cholesterol across generations. Analysis of proband hypertriglyceridemia and lipid/lipoprotein disorders in first-degree family members. Circulation 90:1177-1184
88. Steiner G (2001) Treating lipid abnormalities in patients with type 2 diabetes mellitus. Am J Cardiol 88:37N-40N
89. Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart JC, Ailhaud G (1990) Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem 265:7859-7863
90. Third JL, Montag J, Flynn M, Freidel J, Laskarzewski P, Glueck CJ (1984) Primary and familial hypoalphalipoproteinemia. Metabolism 33:136-146
91. Van Der Vliet HN, Sammels MG, Leegwater AC, Levels JH, Reitsma PH, Boers W, Chamuleau RA (2001) Apolipoprotein A-V: A novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 276:44512-44520
92. Warnick GR (1986) Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol 129:101-123
93. Waterworth DM, Talmud PJ, Humphries SE, Wicks PD, Sagnella GA, Strazzullo P, Alberti KG, Cook DG, Cappuccio FP (2001) Variable effects of the APOC3-482C>T variant on insulin, glucose and triglyceride concentrations in different ethnic groups. Diabetologia 44:245-248
94. Whitfield JB, Martin NG (1983) Plasma lipids in twins. Environmental and genetic influences. Atherosclerosis 48:265-277
95. Wijsman EM (2002) Joint linkage and segregation analysis using Markov chain Monte Carlo methods. In: Camp NJ, Cox A (eds) Quantitative trait loci, methods and protocols. Methods Mol Biol 195:139-161
96. Wijsman EM, Amos C (1997) Genetic analysis of simulated oligogenic traits in nuclear and extended pedigrees: Summary of GAW10 contributions. Genet Epidemiol 14:719-735
97. Wijsman EM, Brunzell J, Jarvik GP, Austin M, Motulsky A, Deeb S (1998) Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex. Arterioscler Thromb 18:215-226
98. Wijsman EM, Peterson D, Leutenegger AL, Thomson JB, Goddard KA, Hsu L, Berninger VW, Raskind WH (2000) Segregation analysis of phenotypic components of learning disabilities. I. Nonword memory and digit span. Am J Hum Genet 67:631-646
99. Williams JT, Duggirala R, Blangero J (1997) Statistical properties of a variance components method for quantitative trait linkage analysis in nuclear families and extended pedigrees. Genet Epidemiol 14:1065-1070
100. Williams RR, Hopkins PN, Hunt SC, Wu LL, Hasstedt SJ, Lalouel JM, Ash KO, Stults BM, Kuida H (1990) Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah. Arch Intern Med 150:582-588
101. Wojciechowski A, Farrall M, Cullen P, Wilson T, Bayliss D, Farren B, Griffin B, Caslake M, Packard C, Shepherd J, Thakker R, Scott J (1991) Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24. Nature 349:161-164
102. Xu C-F, Talmud P, Schuster H, Houlston R, Miller G, Humphries S (1994) Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia. Clin Genet 46:385-397
103. Yang WS, Nevin DN, Peng R, Brunzell JD, Deeb SS (1995) A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc Natl Acad Sci USA 92:4462-4466
104. Yuan B, Neuman R, Duan S, Weber J, Kwok P, Saccone N, Wu J, Liu K, Schonfeld G (2000) Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1-22. Am J Hum Genet 66:1699-1704